Literature DB >> 2450536

The 5' flanking region of the human pS2 gene mediates its transcriptional activation by estrogen in MCF-7 cells.

M Roberts1, J Wallace, J M Jeltsch, M Berry.   

Abstract

The pS2 gene is transcriptionally induced by oestrogen in the human breast cancer cell line MCF-7. We demonstrate here that the 5' flanking sequences (-3000 to +10 bp) of the pS2 gene possess the properties of an oestrogen-inducible promoter. Interestingly, this oestrogen induction could not be demonstrated in transient transfection assays in MCF-7 cells, but only in stably transformed MCF-7 cells, which suggests that some factors responsible for oestrogen induction may be present in limiting amounts in these cells and absent in HeLa cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2450536     DOI: 10.1016/0006-291x(88)90594-3

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  Estrogen-responsive element of the human pS2 gene is an imperfectly palindromic sequence.

Authors:  M Berry; A M Nunez; P Chambon
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

2.  pS2 expression in primary breast carcinomas: relationship to clinical and histological features and survival.

Authors:  A D Thor; F C Koerner; S M Edgerton; W C Wood; M A Stracher; L H Schwartz
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

3.  Expression of pS2 protein in breast cancer.

Authors:  G Crombach; A Ingenhorst; U J Göhring; A Scharl; W Neuhaus; V Möbus; H J Schaeffer
Journal:  Arch Gynecol Obstet       Date:  1993       Impact factor: 2.344

4.  The 5' flanking region of the pS2 gene contains a complex enhancer region responsive to oestrogens, epidermal growth factor, a tumour promoter (TPA), the c-Ha-ras oncoprotein and the c-jun protein.

Authors:  A M Nunez; M Berry; J L Imler; P Chambon
Journal:  EMBO J       Date:  1989-03       Impact factor: 11.598

Review 5.  Importance of Estrogenic Signaling and Its Mediated Receptors in Prostate Cancer.

Authors:  Kin-Mang Lau; Ka-Fai To
Journal:  Int J Mol Sci       Date:  2016-08-31       Impact factor: 5.923

6.  A germline mutation in the BRCA1 3'UTR predicts Stage IV breast cancer.

Authors:  Jemima J Dorairaj; David W Salzman; Deirdre Wall; Tiffany Rounds; Carina Preskill; Catherine A W Sullivan; Robert Lindner; Catherine Curran; Kim Lezon-Geyda; Terri McVeigh; Lyndsay Harris; John Newell; Michael J Kerin; Marie Wood; Nicola Miller; Joanne B Weidhaas
Journal:  BMC Cancer       Date:  2014-06-10       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.